Skip to content

A Pressure Relted Study Comparing a Compression Device and Profore® on Healthy Volunteers

A Phase I, Randomized, Open-label, One-arm, Active Controlled Study to Evaluate the Pressure Interface Between Device and Skin of a Compression Device and Profore® on Healthy Volunteers

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00821808
Enrollment
12
Registered
2009-01-14
Start date
2008-05-31
Completion date
2008-06-30
Last updated
2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

This phase I Healthy Volunteer study will evaluate the pressure interface between the devices (a compression device and Profore®) and the skin, using the PicoPress(TM) pressure transducer at specified time intervals in three distinct locations on the leg, in both the sitting and standing position. It will also assess the variability of interface pressure following application under each test device for each subject over a period of three days (three separate applications).

Interventions

The compression device will be worn for 8 hours each day on one leg. The device will be applied by the same clinician every morning.Interface pressure measurements will be made in both the sitting and standing position at three locations on the leg at the following time intervals: * Immediately following device application * 1 hour * 4 hours * 8 hours

DEVICEProfore®

Profore® will be worn for 8 hours each day on opposite leg. Profore® will be applied by the same clinician every morning.Interface pressure measurements will be made in both the sitting and standing position at three locations on the leg at the following time intervals: * Immediately following device application * 1 hour * 4 hours * 8 hours

Sponsors

ConvaTec Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* over 18 years, willing and able to provide written informed consent. * able to wear the compression device and Profore® and follow the requirements of the clinical investigation plan * an ankle to brachial pressure index (ABPI) of 0.9 or greater * CEAP classification C0-C2 * healthy volunteers

Exclusion criteria

* history of skin sensitivity to any of the components of the study product * participated in a previous clinical study within the past 3 months * active Deep Vein Thrombosis (DVT) or a recent DVT within the last 3 months * exhibited any other medical condition which, according to the Investigator, justifies the subject's exclusion from the study * leg sizes outside the following range: * Ankle - 12cm to 44cm * Calf - 22cm to 60cm * Below knee - 22cm to 68cm

Design outcomes

Primary

MeasureTime frame
To evaluate the amount of pressure and the variability of interface pressure of the two devices on application3 days
To evaluate pressure change of the interface pressure with the compression device and Profore® over time3 days
Safety will be evaluated by the nature and frequency of adverse events.3 days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026